Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
|
|
|
1,001-5,000 employees
View all Myriad Genetics employees
|
|
Biotechnology
|
|
322 N 2200 W, Salt Lake City, Utah 84116, US
|
|
1991
|
|
Personalized Medicine, Prostate Cancer, Genetic Testing, Pharmacogenomics, Pancreatic Cancer, Breast Cancer, Molecular Diagnostics, Companion Diagnostics, Precision Medicine, Prognostic Medicine, Companion Diagnostics, Ovarian Cancer, Hereditary Cancer, Gender Testing, Carrier Screen, Prenatal Screen, Hereditary Cancer, Molecular Diagnostics, Pharmacogenomics, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Précision Medicine, Genetic Testing, Personalized Medicine
|
Michael John is the CEO of Myriad Genetics. To contact Michael John email at [email protected].
The decision makers in Myriad Genetics are Donna Salerno, Gina Campbell Moore, Kevin Haas, etc. Click to Find Myriad Genetics decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.